Baird lowered the firm’s price target on Emerson (EMR) to $143 from $146 and keeps a Neutral rating on the shares. The firm updated its model following results whic introduced moving pieces to its 2026 guidance but the underlying dynamics are stable and healthy.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: